Persky et al.
32
|
24,997 subjects |
18–64 |
ECG abnormalities |
Yes |
Yes (W) |
Mazza et al. Metabolism. 2000 |
130 T2DM patients (60/70) |
53 |
Carotid abnormalities |
Yes |
Yes (W) |
Bo et al. Eur J Clin Invest. 2001 |
1186 T2DM patients (628/558) |
65 |
1) Microalbuminuria by UAE
2) Macroalbuminuria by UAE |
Yes |
1) No
2) Yes |
Tuttle et al.
33
|
277 patients admitted for elective coronary angiography (195/82) |
62 |
Angiographically defined coronary artery disease severity |
Yes (W) |
No |
Ishizaka et al.
34
|
8141 general population (5470/2671) |
57 |
1) Carotid plaque
2) Carotid IMT |
Yes |
1) Yes (M without MS)
2) No |
Kawamoto et al. Intern Med. 2005 |
919 elderly persons (398/521) |
75 |
Carotid IMT |
Yes |
Yes |
Tsioufis et al.
35
|
842 patients with HTN (406/436) |
53 |
1) LVH (echo)
2) Microalbuminuria by UAE |
1) No
2) Yes |
1) No
2) Yes |
Viazzi et al.
36
|
425 patients with HTN (265/160) |
47 |
1) LVH (echo)
2) Carotid abnormalities
3) Microalbuminuria by ACR |
1) Yes (W)
2) Yes (W)
3) No |
1) Yes (W)
2) Yes (W)
3) No |
Tseng Kidney Int. 2005 |
343 patients with T2DM (144/199) |
63 |
Albuminuria by ACR |
Yes |
Yes (patients without HTN) |
Wu et al.
37
|
1005 IgA nephropathy |
31 |
Arterial‐arteriolar lesions (light microscopy semiquantitative scoring) |
Yes |
Yes |
Myllymaki et al.
38
|
202 patients with IgA nephropathy |
41 |
Tubular atrophy (light microscopy semiquantitative scoring) |
Yes |
Yes |
Iribarren et al.
39
|
11,488 subjects free of cardiovascular disease (4966/6522) |
45–64 |
Carotid abnormalities |
Yes (W, white M) |
No |
M=men; W=women; ECG=electrocardiographic; T2DM=type 2 diabetes mellitus; UAE=urinary albumin excretion; IMT=intima‐media thickness;MS=metabolic syndrome; HTN=hypertension; LVH (echo)=left ventricular hypertrophy assessed by echocardiogram; ACR=albumin/creatinine ratio; *expressed as mean or range |